Stability indicating high performance liquid chromatographic assay for the determination of sildenafil citrate in bulk and in formulations

被引:20
作者
Abd-Elbary, A [1 ]
Foda, NH [1 ]
El-Gazayerly, ON [1 ]
机构
[1] Cairo Univ, Fac Pharm, CARAS, Cairo 11562, Egypt
关键词
column liquid chromatography; sildenafil; stability indicating assay; pharmaceutical dosage forms;
D O I
10.1365/s10337-004-0283-z
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A rapid, specific and reliable high performance liquid chromatographic (HPLC) assay of sildenafil in pharmaceutical dosage forms has been developed and evaluated. Reversed phase chromatography was conducted using a mobile phase of methanol: water: acetonitrile (60:20:20) v/v/v, PH 6.1, 0.1% glacial acetic acid, and defection at lambda 290 nm. The recovery and coefficient of variation from six tablets containing 50 mg of sildenafil were 100.90% and 0.45% respectively. Replicate regression analysis of three standard plots in the concentration range (0.01-0.2) mug mL(-1) obtained on three different days gave a correlation coefficient >0.999 and the coefficient of variation of the slopes <1.5%. The assay was precise within day and between days as indicated by ANOVA test. It is suggested that the proposed HPLC method should be used for routine quality control and dosage form assay of sildenafil citrate. The proposed method was also used to study the stability of sildenafil citrate in different dosage forms of the drug.
引用
收藏
页码:561 / 566
页数:6
相关论文
共 9 条
[1]   Sildenafil, a type-5 CGMP phosphodiesterase inhibitor, specifically amplifies endogenous cGMP-dependent relaxation in rabbit corpus cavernosum smooth muscle in vitro [J].
Chuang, AT ;
Strauss, JD ;
Murphy, RA ;
Steers, WD .
JOURNAL OF UROLOGY, 1998, 160 (01) :257-261
[2]   Development of an assay for the simultaneous determination of sildenafil (Viagra) and its metabolite (UK-103,320) using automated sequential trace enrichment of dialysates and high-performance liquid chromatography [J].
Cooper, JDH ;
Muirhead, DC ;
Taylor, JE ;
Baker, PR .
JOURNAL OF CHROMATOGRAPHY B, 1997, 701 (01) :87-95
[3]   Determinaton of sildenafil citrate and related substances in the commercial products and tablet dosage form using HPLC [J].
Daraghmeh, N ;
Al-Omari, M ;
Badwan, AA ;
Jaber, AMY .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2001, 25 (3-4) :483-492
[4]   Stability indicating RP-LC determination of sildenafil citrate (Viagra) in pure form and in pharmaceutical samples [J].
Dinesh, ND ;
Vishukumar, BK ;
Nagaraja, P ;
Gowda, NMM ;
Rangappa, KS .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2002, 29 (04) :743-748
[5]   Safety and efficacy of sildenafil citrate in the treatment of male erectile dysfunction [J].
Goldenberg, MM .
CLINICAL THERAPEUTICS, 1998, 20 (06) :1033-1048
[6]  
Indravadan CB, 2000, INDIAN DRUGS, V37, P319
[7]   Reversed-phase HPLC determination of sildenafil citrate in the presence of its oxidative-induced degradation products [J].
Segall, AI ;
Vitale, MF ;
Perez, VL ;
Palacios, ML ;
Pizzorno, MT .
JOURNAL OF LIQUID CHROMATOGRAPHY & RELATED TECHNOLOGIES, 2000, 23 (09) :1377-1386
[8]   Inhibition of cyclic GMP-binding cyclic GMP-specific phosphodiesterase (type 5) by sildenafil and related compounds [J].
Turko, IV ;
Ballard, SA ;
Francis, SH ;
Corbin, JD .
MOLECULAR PHARMACOLOGY, 1999, 56 (01) :124-130
[9]  
Umrani Dhananjay N., 1999, Indian Journal of Physiology and Pharmacology, V43, P160